»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
NGS ±â¹Ý RNA ½ÃÄö½Ì ½ÃÀå(2024-2028³â)
NGS ±â¹Ý RNA ½ÃÄö½Ì ½ÃÀåÀº 2023-2028³â °£¿¡ 20.52%ÀÇ CAGR·Î ¼ºÀåÇϸç, 66¾ï 5,900¸¸ ´Þ·¯¿¡±îÁö È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â NGS ±â¹Ý RNA ½ÃÄö½Ì ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀΡ¤°úÁ¦, ¾à 25»çÀÇ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº Â÷¼¼´ë ½ÃÄö½Ì ¹æ¹ýÀÇ Ã¤Åà Áõ°¡, ½ÃÄö½Ì Ç÷§ÆûÀÇ ±â¼ú Áøº¸, Æø³ÐÀº Â÷¼¼´ë ½ÃÄö½Ì Á¦Ç°ÀÇ °¡¿ë¼º µîÀÌ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁسâ
2024³â
Á¾·á³â
2028³â
¿¹Ãø ±â°£
2024-2028³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ(2024³â)
18.09%
CAGR
20.52%
ÁõºÐ¾×
66¾ï 5,900¸¸ ´Þ·¯
Â÷¼¼´ë ½ÃÄö½º ±â¼úÀÇ Áøº¸¸¦ ÇâÈÄ ¼ö³â°£ NGS ±â¹Ý RNA ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ÀÌÀ¯ÀÇ Çϳª·Î ½Äº°Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ ½ÃÄö½ºÀÇ ºñ¿ë »è°¨°ú ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¹× Ŭ¶ó¿ìµå ±â¹Ý¡¤¼ÒÇÁÆ®¿þ¾î ÇÁ·Î±×·¥ÀÇ °³¹ßÀÌ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå ±¸µµ
½ÃÀå ¿¡ÄڽýºÅÛ
½ÃÀåÀÇ Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦3Àå ½ÃÀå ±Ô¸ðÀÇ Æò°¡
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2023³â)
½ÃÀå Àü¸Á(2023-2028³â)
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ NGS ±â¹Ý RNA ½ÃÄö½Ì ½ÃÀå(2018-2022³â)
ÃÖÁ¾»ç¿ëÀÚº° ºÐ¼®(2018-2022³â)
±â¼úº° ºÐ¼®(2018-2022³â)
Áö¿ªº° ºÐ¼®(2018-2022³â)
±¹°¡º° ºÐ¼®(2018-2022³â)
Á¦5Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦6Àå ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ¼¼ºÐÈ
½ÃÀå ¼¼ºÐÈ
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
Çмú¿¬±¸ ¼¾ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
ÀÓ»ó ¿¬±¸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
Á¦¾à ±â¾÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ±âȸ
Á¦7Àå ±â¼úº° ½ÃÀå ¼¼ºÐÈ
½ÃÀå ¼¼ºÐÈ
ºñ±³ : ±â¼úº°
ÇÕ¼º¿¡ ÀÇÇÑ ½ÃÄö½Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
À̿ ¹ÝµµÃ¼ ½ÃÄö½Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
´ÜÀÏ ºÐÀÚ ½Ç½Ã°£ ½ÃÄö½Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
±â¼úº° ½ÃÀå ±âȸ
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
¼¼°èÀÇ ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
½Ì°¡Æ÷¸£ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
Áö¿ªº° ½ÃÀå ±âȸ
Á¦10Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀåÀÇ ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦11Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦12Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Agilent Technologies Inc.
Azenta Inc.
BGI Genomics Co. Ltd.
Eurofins Scientific SE
F. Hoffmann La Roche Ltd.
Hamilton Co.
Illumina Inc.
Pacific Biosciences of California Inc.
Perkin Elmer Inc.
Psomagen Inc.
QIAGEN NV
Takara Bio Inc.
Tecan Trading AG
Thermo Fisher Scientific Inc.
Zymo Research Corp.
Á¦13Àå ºÎ·Ï
KSA
NGS-based RNA-seq Market 2024-2028
The NGS-based RNA-seq market is forecasted to grow by USD 6659 mn during 2023-2028, accelerating at a CAGR of 20.52% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased adoption of next generation sequencing methods, technological advancement in sequencing platforms, and availability of wide range of next generation sequencing products.
Market Scope
Base Year 2024
End Year 2028
Series Year 2024-2028
Growth Momentum Accelerate
YOY 2024 18.09%
CAGR 20.52%
Incremental Value $6659 mn
Technavio's NGS-based RNA-seq market is segmented as below:
By End-user
Acamedic and research centers
Clinical research
Pharma companies
Hospitals
By Technology
Sequencing by synthesis
Ion semiconductor sequencing
Single-molecule real-time sequencing
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.
The report on the NGS-based RNA-seq market covers the following areas:
NGS-based RNA-seq market sizing
NGS-based RNA-seq market forecast
NGS-based RNA-seq market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp.. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global NGS-Based RNA-Seq Market 2018 - 2022
Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Technology segment analysis 2018 - 2022
Historic Market Size - Technology Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Acamedic and research centers - Market size and forecast 2023-2028
Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
6.4 Clinical research - Market size and forecast 2023-2028
Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
Chart on Clinical research - Year-over-year growth 2023-2028 (%)
Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
6.5 Pharma companies - Market size and forecast 2023-2028
Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
6.6 Hospitals - Market size and forecast 2023-2028
Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Technology
7.1 Market segments
Chart on Technology - Market share 2023-2028 (%)
Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
7.3 Sequencing by synthesis - Market size and forecast 2023-2028
Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
7.4 Ion semiconductor sequencing - Market size and forecast 2023-2028
Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
7.5 Single-molecule real-time sequencing - Market size and forecast 2023-2028
Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Singapore - Market size and forecast 2023-2028
Chart on Singapore - Market size and forecast 2023-2028 ($ million)
Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
Chart on Singapore - Year-over-year growth 2023-2028 (%)
Data Table on Singapore - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Agilent Technologies Inc.
Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
12.4 Azenta Inc.
Azenta Inc. - Overview
Azenta Inc. - Business segments
Azenta Inc. - Key news
Azenta Inc. - Key offerings
Azenta Inc. - Segment focus
12.5 BGI Genomics Co. Ltd.
BGI Genomics Co. Ltd. - Overview
BGI Genomics Co. Ltd. - Product / Service
BGI Genomics Co. Ltd. - Key offerings
12.6 Eurofins Scientific SE
Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key news
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
12.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.8 Hamilton Co.
Hamilton Co. - Overview
Hamilton Co. - Product / Service
Hamilton Co. - Key offerings
12.9 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
12.10 Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc. - Overview
Pacific Biosciences of California Inc. - Product / Service
Pacific Biosciences of California Inc. - Key offerings
12.11 Perkin Elmer Inc.
Perkin Elmer Inc. - Overview
Perkin Elmer Inc. - Business segments
Perkin Elmer Inc. - Key news
Perkin Elmer Inc. - Key offerings
Perkin Elmer Inc. - Segment focus
12.12 Psomagen Inc.
Psomagen Inc. - Overview
Psomagen Inc. - Product / Service
Psomagen Inc. - Key offerings
12.13 QIAGEN NV
QIAGEN NV - Overview
QIAGEN NV - Product / Service
QIAGEN NV - Key news
QIAGEN NV - Key offerings
12.14 Takara Bio Inc.
Takara Bio Inc. - Overview
Takara Bio Inc. - Product / Service
Takara Bio Inc. - Key offerings
12.15 Tecan Trading AG
Tecan Trading AG - Overview
Tecan Trading AG - Business segments
Tecan Trading AG - Key news
Tecan Trading AG - Key offerings
Tecan Trading AG - Segment focus
12.16 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
12.17 Zymo Research Corp.
Zymo Research Corp. - Overview
Zymo Research Corp. - Product / Service
Zymo Research Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
13.5 Data procurement
13.6 Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations